Bago Laboratories Private Limited
About Bago Laboratories Private Limited
Data last updated:
Bago Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Via Manantial S A, Uruguay. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 10 January 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2002PTC038340. Its GSTIN is 36AABCB7348A1Z0 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹48.5 Lakh and a paid-up capital of ₹48.11 Lakh. It was formerly known as Bgss Pharma Private Limited. It is led by directors Vikram Bery and Bala Murali Krishna Thippabhotla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 512 Meridian Plaza Ameerpet, Hyderabad, Telangana, India – 500016.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.17 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹8.51 Lakh (net margin 19.3%) and EBITDA of ₹11.91 Lakh (EBITDA margin 27%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹24 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Bago Laboratories has one previous CIN (Corporate Identification Number): U24239AP2002PTC038340. The current CIN is U24239TG2002PTC038340, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2002PTC038340 | Current |
| U24239AP2002PTC038340 | Previous |
Contact details
Bago Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address512 Meridian Plaza Ameerpet, Hyderabad, Telangana, India – 500016
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Bago Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bago Laboratories Private Limited
FY 2025 filings availableBago Laboratories Private Limited reported revenue of ₹44.17 Lakh (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27% | ||||
| Net Profit Margin | 19.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bago Laboratories Private Limited, buy the company report.
Board of directors of Bago Laboratories Private Limited
Bago Laboratories has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikram Bery | Director | 01 May 2008 | 18 Years 5 Months | Current |
| Bala Murali Krishna Thippabhotla Also directs: Apogen Remedies Private Limited, Exarmed Pharma LLP | Director | 01 May 2008 | 18 Years 5 Months | Current |
Auditor
Bago Laboratories Private Limited is audited by SIRISH & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SIRISH & CO | FY 2020 | 003909S |
Shareholding
The shareholding of Bago Laboratories Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Bago Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bago Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bago Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bago Laboratories has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCB7348A1Z0 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bago Laboratories Private Limited, buy the company report.
Recent activity
Bago Laboratories Private Limited has 4 board changes on record since 2008: 2 appointments and 2 cessations. The latest: Rama Krishna Madhavapeddi ceased to be Director on 27 Oct 2017.
Frequently asked questions
Bago Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 10 January 2002 (24+ years old) and is registered under CIN U24239TG2002PTC038340.
Bago Laboratories has 2 current directors:
- Vikram Bery - Director
- Bala Murali Krishna Thippabhotla - Director
The latest financial statements of Bago Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bago Laboratories is 36AABCB7348A1Z0, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Bago Laboratories is U24239TG2002PTC038340. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bago Laboratories was incorporated on 10 January 2002, making it 24+ years old. It is registered with the Registrar of Companies, Hyderabad.
Rama Krishna Madhavapeddi ceased to be Director on 27 Oct 2017. Bala Murali Krishna Thippabhotla was appointed as Director on 01 May 2008. Sistla Venkateswarlu ceased to be Director on 01 May 2008. Bago Laboratories has 4 board changes on record in total.
The registered office of Bago Laboratories is at 512 Meridian Plaza Ameerpet, Hyderabad, Telangana, India – 500016.
Bago Laboratories operates in the chemicals and materials industry, in the chemical distribution and retail segment.
Bago Laboratories has open charges of ₹24 Lakh and no satisfied charges on record as per latest MCA filings.